miR-17-5p and miR-20a also repress BMPRII expression, influencing its regulation in the IL-6/STAT3 signaling axis, an important inflammatory pathway implicated in PAH pathology (184, 185). Here, BMPR2 is linked to pulmonary arterial hypertension.